At Café Scientifique, you can explore the latest ideas in science and technology in a relaxed setting. Enjoy listening to a short talk before engaging in debate and discussion with our guest speaker and audience.
We’ll be joined by Dr Géza Gergely Ambrus on Tuesday 2 May from 6:30 – 8:00pm.
Join us to discover the latest advances in neuroscience and the possibility of creating machines that can read human minds.
Dr Géza Gergely Ambrus will explore how machine learning algorithms could decode brain activity and reconstruct subjective experiences, and what this might mean for fields such as neuroprosthetics and brain-computer interfaces.
We will consider how this research could help us understand how humans think, but also raise important ethical questions about the potential use of such technologies to access our innermost thoughts and memories. This talk is suitable for anyone interested in neuroscience, artificial intelligence, or the ethics of technology.
This event will be held at The Black Cherry in Boscombe, Bournemouth. Although the talk starts at 6:30pm, the café will be open early so we encourage you to arrive early for a drink and a bite to eat before the talk starts.

Café Sci – Tuesday 7 February 2023: Challenging news negativity
Café Sci: Tuesday 6 September – How can cities cope with climate change?










Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
Prof Marahatta promoting BU-Nepal collaboration
3C Online Social: Research Culture, Community & Can you Guess Who? Thursday 26 March 1-2pm
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease